A prominent Cancer Research UK spokesperson notes an urgent need for better glioblastoma treatments and explains that this research, partially funded by the charity, could help slow tumor growth and extend patients’ lives.

The study is framed as a potential step toward more effective therapies, with researchers emphasizing the impact on future treatment options for glioblastoma.

Among the key researchers are Dr. Saverio Tardito and Sam Godfrey, who highlight funding as a critical factor in advancing this work and the urgency of addressing glioblastoma.

A multinational European team has identified a hidden vulnerability in glioblastoma tied to vitamin B metabolism, proposing a specialised diet combined with steroid anti-inflammatory drugs to slow tumor growth.

The findings point to new diagnostic and therapeutic strategies, underscoring how metabolic interventions could augment existing glioblastoma treatments.

Specifically, restricting dietary methionine, together with steroid treatment, appears to deprive glioblastoma cells of metabolites needed for growth, suggesting a potential diet-based adjunct to current therapies.